Dvision of Clinical, Social and Administrative Sciences

Faculty


kamalBig

Khalid M. Kamal, Ph.D.

Associate Professor of Pharmaceutical Administration

418 B Mellon
T 412.396.1926
kamalk@duq.edu

Educational Background

Bachelor of Pharmacy (B. Pharm), University of Bombay, India
M.S. (Pharmacology), University of Bombay, India
Ph.D. (Pharmacy Administration), West Virginia University

Research Interests

Application of decision and cost-effectiveness analysis in health policy and medicine
  • Economic evaluations of treatments used in musculoskeletal disorders and COPD
  • Measuring patient-reported outcomes in chronic conditions
Use of Electronic Medical Records as a tool for quality improvement in the healthcare system


Visiting Professor

Kobe-Gakuin University Faculty of Pharmaceutical Sciences, Kobe, Japan (October 2008).


Courses Taught

Graduate Courses
  • Pharmacoeconomic Evaluations (GPSC 590) - 3 Crs. (Spring; 100%)
  • Patient-Reported Health Outcomes (GPSC 591) - 3 Crs. (Fall; 100%)
  • Research Methods in Pharmacy Administration (GPSC 589) - 3 Crs. (Fall; Team Taught - 40%; Course master)
Undergraduate Courses
  • The American Healthcare System (PHBA 410) - 2 Crs. (Spring; Team Taught - 30%; Course master)
  • Pharmacy Practice V (PHPR 447) - 3 Crs. (Fall; Team Taught - 34%)
  • Drug Literature Evaluation (PHPR 448-71) - 2 Crs. (Fall; Team Taught - 30%)

Publication of Teaching Materials

  • Westrick SC, Kamal KM, Moczygemba LR, Breland ML, Heaton PC. Characteristics of Social and Administrative Sciences Programs and Strategies for Student Recruitment and Development. Accepted - Research in Social and Administrative Pharmacy.
  • Elliot J, Koerner P, Heasley J, Kamal KM. Enhancing student learning of pediatrics through the use of active learning strategies. American Journal of Pharmaceutical Education. 2012;76(1).
  • Surratt CK, Kamal KM, Wildfong PD. Research funding expectations as a function of faculty teaching/administrative workload. Research in Social and Administrative Pharmacy, Available online 23 July 2010.
  • Kamal KM, Sakamaki A, Bricker JD, Kawasaki K. An elective course in pharmacoeconomics for pharmacy students in Japan - A transcultural experience. Currents in Pharmacy Teaching and Learning. 2010; 2:218-227.
  • Skomo M, Kamal KM, Berdine H. A required course in the development, implementation, and evaluation of clinical pharmacy services. American Journal of Pharmaceutical Education. 2008; 72(5): Article 109.

Presentation of Teaching

  • Westrick SC, Kamal KM, Moczygemba LR, Breland ML, Heaton PC. Characteristics of
    Economic, Social and Administrative Sciences (ESAS) Programs and Strategies for Student Recruitment and Development. Podium Presentation. The annual meeting of American Pharmacists Association (APhA), New Orleans, March 2012.

  • Surratt CK, Kamal KM, Wildfong PD. Research funding expectations as a function of faculty teaching/administrative workload. The annual meeting of American Association of Colleges of Pharmacy (AACP), Seattle, July 2010.
  • Kamal KM, Sakamaki A, Shirakawa S, Kawasaki K, Akaho E, Bricker JD. Need for pharmacoeconomics in the Japanese healthcare system: Experiences from teaching an elective course for pharmacy students in Kobe Gakuin University, Kobe. The annual meeting of Japan Pharmacist Association (JPA) Congress of Pharmacy & Pharmaceutical Science, Shiga, Japan, October, 2009.
  • Kamal KM, Sakamaki A, Bricker JD, Kawasaki K. An elective course in pharmacoeconomics for pharmacy students in Japan - A transcultural experience. The annual meeting of American Association of Colleges of Pharmacy (AACP), Boston, July 2009.
  • Giannetti V, Lasilla H, O'Neil C, Kamal KM. Integration of public health into an American Healthcare Systems course. The annual meeting of the American Association of Colleges of Pharmacy (AACP), Chicago, July 2008.
  • Skomo M, Kamal KM, Berdine H. Integration of CAPE Outcomes into a pharmacy practice course through application of business plan models. The annual meeting of American Association of Colleges of Pharmacy (AACP), Orlando, July 2007.

Scholarship

Book Chapter

  • Kamal KM. Operationalizing research. In: Aparasu R, ed. Research Methods for Pharmaceutical Practice and Policy. Royal Pharmaceutical Society of Great Britain (Pharmaceutical Press): 2010.

Book Review

  • Jordan Braverman. Health Economics. Pharmacy Business Administration Series. Chicago, IL: Pharmaceutical Press; 2009. American Journal of Pharmaceutical Education, 2010; 74 (5): Article 94.

Publications

  • Kamal KM, Zacker C, Civitarese L. Impact of non-medical switching between different angiotensin receptor blockers (ARBs) on continuity of care in a primary care setting Accepted - American Journal of Pharmacy Benefits.
  • Chopra I, Kamal KM. A systematic review of quality of life instruments in long-term breast cancer survivors. Health and Quality of Life Outcomes 2012, 10:14 (31 January 2012).
  • Naik S, Kamal KM, Keys PA, Mattei TJ. Evaluating the cost-effectiveness of tiotropium versus salmeterol in the treatment of Chronic Obstructive Pulmonary Disease. ClinicoEconomics and Outcomes Research, 2010; 2: 25-36.
  • Yoder JL, Kamal KM. A systematic review of economic analyses studying rituximab in R-CHOP therapy in patients with Non-Hodgkin Lymphoma. The Open Cancer Immunology Journal, 2009, 2:1-9.
  • Kamal KM, Desselle S, Rane P, Parekh R, Zacker C. Content analysis of FDA warning letters to manufacturers of pharmaceuticals and biologics. Drug Information Journal. 2009;43(4):385-393.
  • Khanna R, Scott VG, Kavookjian J, Kamal KM, Miller LA, Neal WA. Using the Theory of Reasoned Action to determine physicians' intention to measure body mass index in children and adolescents. Research in Social and Administrative Pharmacy. 2009;5(2): 170-81.
  • Kamal KM. Treating Crohn's Disease in the 21st Century: An evidence-based review of the management of refractory disease. First Report' March 2007. Invited submission for Continuing Medical Education sponsored by University of Cincinnati and Princeton Media Associates.
  • Kamal KM, Madhavan SS, Hornsby JA, Miller LA, Scott V, Kavookjian J. US rheumatologists' prescribing practices for anti-TNF agents. Published as an abstract in the 'Research Highlights' section of Nature Clinical Practice Rheumatology 2007;3(4):196-197.
  • Kamal KM, Madhavan SS, Hornsby JA, Miller LA, Scott V, Kavookjian J. Use of tumor necrosis factor inhibitors in rheumatoid arthritis: A national survey of practicing United States rheumatologists. Joint Bone Spine, 2006;73 (6):718-724. Also, published in Revue du Rhumatisme, 2006; 73(12):1387-94 (French).
  • Kamal KM, Miller LA, Kavookjian J, Madhavan SS. Alternative decision analysis modeling in the economic evaluation of tumor necrosis factor inhibitors in patients with rheumatoid arthritis. Seminars in Arthritis and Rheumatism, 2006:36(1):50-60.
  • Tompkins NO, Kamal KM, Chapman D. West Virginia health education assessment project. Journal of School Health 2005;75(6):193-198.
  • Orsini L, Limpa-Amara S, Crown WH, Stanford RH, Kamal KM. Asthma hospitalization risk and costs for patients treated with fluticasone propionate versus montelukast. Annals of Asthma, Allergy and Immunology 2004;92:523-529.
  • Dino GA, Kamal KM, Kalsekar ID, Fernandes AW, Horn KA. Stages of change and smoking cessation outcomes in adolescents. Addictive Behavior 2004;29(5):935-40.
  • Kamal KM, Madhavan SS, Maine LL. Pharmacy and immunization services: Pharmacists' participation and impact. Journal of American Pharmaceutical Association 2003;43(4):470-82.
  • Kamal KM, Madhavan SS, Amonkar MM. Determinants of adult influenza and pneumonia immunization rates. Journal of American Pharmaceutical Association 2003;43(3):403-11.
  • Kamal KM, Madhavan SS, Maine LL. Pharmacists and immunization services: Impact of American Pharmaceutical Association's (APhA) Immunization Training Certification Program. American Journal of Pharmaceutical Education 2003;67(4):article 124.
  • Nair AM, Mungantiwar AA, Kamal KM, Saraf MN. Modulation of invitro anaphylaxis by furosemide. Indian Journal of Pharmacology 1997;29:182-186.
  • Nair AM, Mungantiwar AA, Kamal KM, Saraf MN. Antiallergic potential of furosemide. Indian Journal of Experimental Biology 1997;35:466-469.


Selected Scientific Presentation and Published Abstracts

  • Kamal KM, Zacker C, Civitarese L. Impact of non-medical switching between different angiotensin receptor blockers (ARB) on blood pressure and medical resource utilization. The annual meeting of American Society for Hypertension (ASH), New York, May 2011. Abstract published in The Journal of Clinical Hypertension 2011; 13(Suppl.1):A155.
  • Kamal KM, Civitarese L. Use of electronic medical records for clinical research in the management of type 2 diabetes. The annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Baltimore, May 2011. Abstract published in Value in Health 2011; 14:A101.
  • Kamal KM, Zacker C, Civitarese L. Use of electronic medical records to assess the clinical and economic impact of non-medical switching between different angiotensin receptor blockers (ARBs). The annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Baltimore, May 2011. Abstract published in Value in Health 2011; 14:A50.
  • Chopra I, Kamal KM. A systematic review of quality of life instruments in long term breast cancer survivors. The annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Baltimore, May 2011. Abstract published in Value in Health 2011; 14:A172.
  • Shah D, Kamal KM. Caregiver burden in schizophrenia - a systematic review. The annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Baltimore, May 2011. Abstract published in Value in Health 2011; 14:A195.
  • Lobo C, Kamal KM. Quality of life and fibromyalgia - a systematic literature review. The annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Baltimore, May 2011. Abstract published in Value in Health 2011; 14:A131.
  • Kamal KM, Patel B, Atreja N, Zacker C. Impact of multiple sclerosis on patients: A systematic review of the evidence. The annual meeting of Academy of Managed Care Pharmacy (AMCP), Minneapolis, April 2011 (Accepted).
  • Kamal KM, Atreja N, Patel B, Zacker C. Systematic review of the impact of treatments on quality of life, work productivity, and adherence in multiple sclerosis. The annual meeting of Academy of Managed Care Pharmacy (AMCP), Minneapolis, April 2011 (Accepted).
  • Henlyshyn E, Kamal KM. Pulmonary rehabilitation: A budget impact model to evaluate how policy changes will impact reimbursement from a managed care perspective. The annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Atlanta, May 2010. Abstract published in Value in Health 2010;13(3):A198.
  • Ombengi D, Kamal KM, Rihn T, Mattei T. Assessment of medication utilization pattern of patients with systolic hypertension and compelling indications in a primary care practice. The annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Atlanta, May 2010. Abstract published in Value in Health 2010;13(3):A178.
  • Patel B, Kamal KM, Atreja N. Inpatient resource utilization in bronchial and lung cancer: analysis of 2007 Healthcare Utilization and Project (HCUP) data. The annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Atlanta, May 2010. Abstract published in Value in Health 2010;13(3):A43.
  • Patel B, Kamal KM, Atreja N. A systematic review of economic analyses of Rasagiline and Entacapone in Parkinson's disease. The annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Atlanta, May 2010. Abstract published in Value in Health 2010;13(3):A139.
  • Atreja N, Kamal KM, Patel B. Incremental medical cost of musculoskeletal disorders in the United States: Estimates from 2006 Medical Expenditure Panel Survey (MEPS) data. The annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Atlanta, May 2010. Abstract published in Value in Health 2010;13(3):A124.
  • Atreja N, Kamal KM, Patel B. A pharmacoeconomic review of economic analyses of biologic therapies in patients with Ankylosing Spondylitis. The annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Atlanta, May 2010. Abstract published in Value in Health 2010;13(3):A127.
  • Dudash K, Kamal KM. Use of tumor necrosis factor inhibitors in Ankylosing Spondylitis: A cost-effectiveness analysis and budget impact analysis. The annual meeting of Academy of Managed Care Pharmacy (AMCP), San Diego, April 2010 (Won the Best Paper Award).
  • Rane PB, Kamal KM, Keys P, Giannetti V. Hospital resource utilization in patients with chronic obstructive pulmonary disease: An analysis of the 2005 National Inpatient Sample data. The annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Orlando, May 2009. Abstract published in Value in Health 2009;12(2):A127.
  • Parekh R, Kamal KM, Mihalyo M, Runyon A. Medication costs and utilization in a Hospice care. The annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Orlando, May 2009. Abstract published in Value in Health 2009; 12(2):A82.
  • Mandock k, Tomko J, Giannetti V, Kamal KM. Non-adherence to pharmacotherapy as a potential risk factor for relapse to substance use disorder in dual diagnosis patients. The Annual Meeting of the College of Psychiatric and Neurologic Pharmacists, Jacksonville, April 2009.
  • Kamal KM, Rane P, Parekh R, Desselle S, Zacker C. Analysis of FDA warning letters and notices to manufacturers of pharmaceuticals concerning health outcomes-related promotional claims violations. The annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Toronto, May 2008. Abstract published in Value in Health 2008;11(3):A53.
  • Parekh HH, Kamal KM, Smith MJ, Skomo M. Resource utilization among inpatients with rheumatoid arthritis – An analysis of 2004 Healthcare Cost and Utilization Project data. The annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Toronto, May 2008. Abstract published in Value in Health 2008;11(3):A262.
  • Parekh HH, Kamal KM, Skomo M, Smith MJ. Trends in hospitalizations among inpatients with Rheumatoid Arthritis – An analysis of 2002-2004 Healthcare Cost and Utilization Project data. The annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Toronto, May 2008. Abstract published in Value in Health 2008;11(3):A262.
  • Shah N, Kamal KM. Review of Quality of Life instruments in Migraine. The annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Toronto, May 2008. Abstract published in Value in Health 2008;11(3):A145.
  • Khanna R, Scott VG, Kavookjian J, Kamal KM, Miller LA, Neal WA. Physicians’ intention to measure body mass index in children and adolescents: A theory of Reasoned Action Model. The annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Toronto, May 2008. Abstract published in Value in Health 2008;11(3):A167.
  • Parekh R, Rane P, Kamal KM, Desselle S. Content analysis of FDA warning letters to manufacturers concerning promotional violations. The annual meeting of American Managed Care Pharmacy (AMCP), Boston, October 2007. Abstract published in Journal of Managed Care Pharmacy 2007; 13(8):692.
  • Khanna R, Smith MJ, Kamal KM. Utilization of chronic arthritis-related healthcare services by children and adolescents in a Medicaid population. The annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Washington, May 2007. Abstract published in Value in Health 2007;10(3):A121.
  • Naik S, Kamal KM, Keys P, Mattei T. Evaluating the cost-effectiveness of tiotropium in the treatment of moderate chronic obstructive pulmonary disease. The annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Washington, May 2007. Abstract published in Value in Health 2007;10(3):A178.
  • Naik S, Kamal KM. Measurement of quality of life in restless legs syndrome. The annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Washington, May 2007. Abstract published in Value in Health 2007;10(3):A94.
  • Parekh HH, Kamal KM. Economic evaluation of tumor necrosis factor inhibitors in the treatment of ankylosing spondylitis. The annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Washington, May 2007. Abstract published in Value in Health 2007;10(3):A118.
  • Rane PB, Kamal KM. A review of health related quality of life instruments used in children and adolescents with epilepsy. The annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Washington, May 2007. Abstract published in Value in Health 2007;10(3):A94.
  • Parekh HH, Kamal KM. Tumor Necrosis Factor Inhibitors - A pharmacoeconomic review of its use in Ankylosing Spondylitis. Midwest Social and Administrative Pharmacy Conference, Minneapolis, July 2006. The annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Washington, May 2007. Abstract published in Value in Health 2007;10(3):A120.
  • Parekh RH, Kamal KM, Desselle S. Smoking status and pneumonia immunization: Findings from the 2005 Behavioral Risk Factor Surveillance System (BRFSS) data. The annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Washington, May 2007. Abstract published in Value in Health 2007; 10(3):A168.
  • Parekh H, Kamal KM. A systematic review of quality of life measures in ankylosing spondylitis. The annual meeting of the American Pharmacists Association (APhA), Atlanta, GA, March 2007. Abstract published in Journal of American Pharmacists Association 2007;47(2):255.
  • Kamal KM, Miller LA. A cost-effectiveness analysis of treatment strategies including tumor necrosis factor inhibitors and abatacept for patients with active rheumatoid arthritis. The annual Meeting of the Society for Medical Decision Making, Boston, MA, October 2006.
  • Naik S, Kamal KM. Estimating cost-effectiveness of tiotropium for treating chronic obstructive pulmonary disease. Midwest Social and Administrative Pharmacy Conference, Minneapolis, July 2006.
  • Tagliavia N, Kamal KM, Desselle S. A comparison of health-related quality of life (HRQoL) of persons with and without arthritis or chronic joint symptoms (CJS). Midwest Social and Administrative Pharmacy Conference, Minneapolis, July 2006. Also presented at the annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Philadelphia, May 2006 Abstract published in Value in Health 2006; 9(3):A29.

Podium/Invited Presentations

  • Kamal KM. Electronic Medical Records: Connecting patient care with health outcomes research. WVU Student ISPOR Chapter at West Virginia University School of Pharmacy, November 2011.
  • Parekh R, Mihalyo M, Runyon A, Kamal KM. Impact of pharmacist-led intervention on medication costs and utilization in a hospice care: A claims data analysis. The National Hospice Palliative Care Organization (NHPCO) meeting, September 25, 2009 [Presenter - Mihalyo M & Runyon A].
  • Kamal KM, Giannetti V. The science in social science. Duquesne University External Seminar Series, Mylan School of Pharmacy, September 9, 2009 [Seminar Series Co-ordinator: Dr. Jane Cavanaugh]
  • Kamal KM. Introduction to Budget Impact Analysis. WVU Student ISPOR Chapter at West Virginia University School of Pharmacy, April 2009.
  • Kamal KM. Overview of faculty teaching and research at Duquesne University Mylan
  • School of Pharmacy. Visiting Professor, Kobe-Gakuin University School of Pharmacy, Kobe, Japan, October 2008.
  • Kamal KM. Need for pharmacoeconomics in the Japanese Healthcare System. Visiting Professor, Kobe-Gakuin University School of Pharmacy, Kobe, Japan. Invited presentation at Kobe City Medical Center General Hospital, October 2008.

Grants and Contracts

  • Economic and humanistic outcomes in patients with advanced renal cell carcinoma; role PI. $7,000 - Arnold Consultancy PI Technology, LLC, . New York; 2010
  • Examining the consequences of multiple sclerosis from a patient perspective; role PI. $20,268.75 - Novartis; 2010
  • Non-medical switching between different ARBs on continuity of care and BP control; role PI. $50,556.25 Novartis; 2009-2011
  • Quality improvement in physician process and patient outcomes in Scholarship Award diabetes care; role PI. $5,000 - DU Presidential Scholarship Award;  2008-2009
  • Pharmacoeconomic evaluation of TNF inhibitors in AS; role PI. $9,887 - DU Faculty Development Fund; 2007-2010
  • Consequences of pharmacy benefits design; role Co-I. $22,696.33 - Novartis; 2006-2007
  • Content analysis of FDA warning letters to manufacturers; role Co-I. $7,389.37 - Novartis; 2006-2007

Honors and Awards

  • Recipient of the Mylan School of Pharmacy's Faculty Award for outstanding contributions in teaching, service, and scholarship, 2010.
  • Nominated by Duquesne University Mylan School of Pharmacy for Duquesne University President's Faculty Award for Excellence in Scholarship, 2010.
  • Dudash K, Kamal KM. Use of tumor necrosis factor inhibitors in Ankylosing Spondylitis: A cost-effectiveness analysis and budget impact analysis. Selected as the best paper in the Student/Fellows/Residents presentation category at the annual meeting of Academy of Managed Care Pharmacy (AMCP), San Diego, April 2010.
  • Khanna R, Kamal KM, Smith M. Utilization and costs of drugs and office services among recipients of Medicaid with rheumatoid arthritis with versus without comorbid depression. Association of Rheumatology Health Professionals Graduate Student Award (2006)
  • Graduate Research Award, School of Pharmacy, WVU (2001-2002)
  • All India Council of Technical Education Junior Research Fellowship (1994-1996)

Professional Student Advising

  • Faculty Advisor, Student National Pharmaceutical Association (DU Chapter), 2010 - Present
  • Faculty Advisor, Duquesne University ISPOR Student Chapter, 2006 - Present.
  • Faculty Advisor, Duquesne University Indian Student Association, 2006 - Present.

Manuscript Reviewer

  • Value in Health
  • Journal of Rheumatology
  • Clinical Therapeutics
  • Journal of Managed Care Pharmacy
  • Research in Social and Administrative Pharmacy
  • American Journal of Health-System Pharmacy
  • Expert Review for Medical Devices

Professional Affiliations

  • International Society for Pharmacoeconomics & Outcomes Research (ISPOR)
  • Association of Rheumatology Health Professionals (ARHP)
  • American Association of Colleges of Pharmacy (AACP)
  • Society for Medical Decision Making (SMDM)
  • Rho Chi Honor Society
  • Economic Club of Pittsburgh

Faculty and Staff

Pharmaceutical Sciences

Clinical Social and Administrative

Staff

Faculty main

Bulletin Board

faculty-highlights

School Highlights